Transcranial magnetic induction is a promising and powerful tool in the field of neuropsychiatry and has widespread application in basic neurophysiological & neuropsychiatric research, treatment of depression and other psychiatric disorders. Since it is a relatively new technique approved by the FDA, more prospective studies and clinical trials are needed to provide more accurate data and help optimize the treatment.
Introduction
Since its inception to modern medicine in the late 1980s, Transcranial magnetic stimulation (Transcranial Magnetic Stimulation) has been employed for nearly two decades as a noninvasive clinical tool in the treatment of patients with depressive disorders. It is a relatively novel form of treatment in the field of neurophysiology and its efficacy is based on electromagnetic induction of electric currents in the brain. As a therapy, it tends to be well-tolerated and painless and is used for stimulation and activation of neurons causing hyperpolarization or depolarization of the electro-physiologically active tissues. [1] Transcranial Magnetic Stimulation can measure various cortical phenomena, including cortical inhibition and plasticity [2] and it can also be employed in the diagnosis and treatment of certain neuropsychiatric disorders including depression, strokes and migraines amongst others. Transcranial Magnetic Stimulation serves as a means of perturbing the brain and effecting modulation of brain function. Electromagnetic induction can be applied solitarily as single induction or as repeated pulses at predetermined intervals over a time variable, which can be customized based on the underlying condition and treatment goals. The principle of Transcranial Magnetic Stimulation is based on the law of electromagnetic induction formulated by Faraday in 1831. This law expounds that when a time-varying current is flowing around a primary coil, it creates a changing electromagnetic field and induces a secondary current in conductors found within a predetermined physical proximity. According to Lenz's law, this secondary current will flow in an anti-parallel direction to the primary current. [14] The brain is capable of similar electrical conduction and therefore can be electrically stimulated using pulsed magnetism in immediate proximity.
In 1985, Barker and colleagues developed a device capable of magnetic field generation of sufficient intensity to depolarize cortical neurons. This device was capable of generating a large electrical charge over a very short interval. This formed the basis of all modern devices. [15] In Transcranial Magnetic Stimulation, electrical charges stored in capacitors discharge in a programmed periodical manner directly over the scalp, producing a time-varying electrical field. This electrical field then produces a transient electromagnetic field causing an electrical current to flow in secondary conducting materials, in this case neurons, altering their electrical environment causing them to depolarize. [16] This periodical discharge of electric charge generates a changing magnetic field that lasts approximately 100-300 milliseconds with intensity ranging from 1 to 2.5 Tesla. This intensity approximates that of magnetic resonance scanners and is 20,000 to 50,000 times more intense than the magnetic field of the Earth.
[17] Once aligned and arranged, the magnetic field passes through the soft tissues of the head and the skull without resistance, and so inducing a secondary electrical current in the brain, which results in the depolarization of neurons but surpassing their depolarization threshold.
[17]
The Transcranial Magnetic Stimulation apparatus consists of a concealed wire coil, placed on the subject's scalp over the targeted neural centers. The location on the scalp is chosen based on the patient's neuropsychiatric condition. The coil is connected to capacitors through electric cableing. The capacitors are charged by a power source and they then discharge through the coil when the device is triggered. The two most commonly used configurations are the "circular" configuration, and the "figure eight" configuration.. The circular arrangement tends prevents diminution of sheer power, "8" shaped coils produce a more focused magnetic field when placed tangentially over the target, bringing about better spatial resolution of activation. Transcranial Magnetic Stimulation has also been used in post stroke patients along with physical therapy for rehabilitation. The technology also measures neuroplastic changes secondary to physical therapy. In a study done in post stroke patients by Kim et al, it was found that the study group which received Repetitive Transcranial Magnetic Stimulation showed significant improvement in movement accuracy and speed compared to those who received placebo. [51] A recent study showed that Repetitive Transcranial Magnetic Stimulation in conjunction with Physical therapy resulted in better clinical improvement in stroke patients than just physical therapy alone. [52] Several other studies support the benefits of Transcranial Magnetic Stimulation for neuro-rehabilitation in post-stroke patients. [53] [54] [55] This technology serves as a diagnostic tool in dementia and age related cognitive decline. It shows changes in intra-cortical excitation and inhibition. [56] This could help differentiate mild cognitive defects from Alzheimer's disease [57] [58] [59] , fronto-temporal dementia [60] , subcortical vascular dementia [61] as well as normal and abnormal aging [62] . Several studies show that Transcranial Magnetic Stimulation could also improve memory function in elderly patients. [ Transcranial Magnetic Stimulation also helps Parkinson's patients by stimulating dopamine secretion in the caudate nucleus. [70] Several prospective studies are needed in these areas.
Another interesting potential application for transcranial magnetic stimulation is in the alleviation of chronic neuropathic pain. Singlesession repetitive TMS has demonstrated some evidence suggestive of therapeutic potential albeit transient in the management of intractable neuropathic pains. The findings of one study showed that daily high-frequency rTMS over the primary motor cortex is tolerable to the patient, and provides modest pain relief in neuropathic pain patients. The nature of the relief has been transient thus far but more data is needed. [71] Conclusion 
